Accelerated Development and Manufacturing of Oral Small Molecules to be Discussed by Catalent Applied Drug Delivery Institute and JLABS

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): PR Newswire
  • Source:
    PR Newswire US. 03/30/2023.
  • Additional Information
    • Alternate Title:
      PRWEB
    • Subject Terms:
    • Abstract:
      The Catalent Applied Drug Delivery Institute, which was established as a cross-industry consortium to accelerate the adoption of advanced drug delivery technologies, today announced that it will hold a symposium in affiliation with Johnson & Johnson Innovation - JLABS (JLABS), entitled "The Road to IND: Accelerating Development & Manufacturing of Oral Small Molecules", on Tuesday, April 4, 2023, at JLABS @ San Diego. Experts and speakers from Catalent and JLABS will be joined by speakers from The Johnson & Johnson Family of Companies (Johnson & Johnson), UC San Diego, and Galileo Biosystems. [ABSTRACT FROM PUBLISHER]